Nucleic Acid Immunotherapeutics for Cancer

Shen, TT; Zhang, Y; Zhou, SR; Lin, SB; Zhang, XB; Zhu, GZ

Zhang, XB (corresponding author), Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Collaborat Innovat Ctr Mol Engn & Theranost, Coll Chem & Chem Engn,Mol Sci & Biomed Lab, Changsha 410082, Hunan, Peoples R China.; Zhang, XB (corresponding author), Hunan Univ, Coll Biol, Collaborat Innovat Ctr Mol Engn & Theranost, Changsha 410082, Hunan, Peoples R China.; Zhu, GZ (corresponding author), Virginia Commonwealth Univ, Dept Pharmaceut, Ctr Pharmaceut Engn & Sci, Sch Pharm, Richmond, VA 23298 USA.; Zhu, GZ (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA.; Zhu, GZ (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23298 USA.; Lin, SB (corresponding author), Sun Yat Sen Univ, Dept Rehabil Med, Ctr Translat Med, Precis Med Inst,Affiliated Hosp 1, Guangzhou 510080, Peoples R China.

ACS APPLIED BIO MATERIALS, 2020; 3 (5): 2838

Abstract

The past decade has witnessed the blossom of two fields: nucleic acid therapeutics and cancer immunotherapy. Unlike traditional small molecule medicin......

Full Text Link